Transcenta Announces the Appointment of Daniel Weng as CFO

/PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in...

Related Keywords

Guangzhou ,Guangdong ,China ,Australia ,Taiwan ,Shanghai ,Sydney ,New South Wales ,Suzhou ,Jiangsu ,Boston ,Massachusetts ,United States ,Beijing ,Hangzhou ,Zhejiang ,Daniel Weng ,Xueming Qian ,Los Angeles ,Amgen ,Cstone Pharmaceuticals ,Clinical Development Centers ,Transcenta Holding ,Product Development Center ,Translational Research Center ,University Of Sydney ,Prnewswire Transcenta Holding Limited ,Honeywell ,Business Development ,Holding Limited ,Everest Medicines ,Manufacturing Facility ,External Partnering Center ,Transcenta Holding Limited ,Biotechnology ,Health Care Amp Hospitals ,Pharmaceuticals ,Medical Pharmaceuticals ,Personnel Announcements ,